HOME >> BIOLOGY >> NEWS
New global survey demonstrates an increasing demand for new treatments for non-Hodgkin's Lymphoma

10 December 2001, 43rd Annual Meeting of the American Society of Hematology, Orlando, US - In a survey of 230 physicians from around the world, the majority interviewed (63%) have seen an increase in the last five years in the number of patients suffering from non-Hodgkin's lymphoma (NHL). The average reported increase in cases of NHL, a form of cancer of the immune system, was 13%.

The survey also showed that 9 out of 10 physicians (91%) who prescribe MabThera (rituximab) for the treatment of this increasingly common form of cancer, said there is a significant improvement in their patients' quality of life.

The survey found that physicians are increasingly prescribing MabThera for the treatment of NHL. Of those who have prescribed MabThera, 92% said their usage increased over the last three years and, of these, over half (62%) said their increased prescribing of MabThera in combination with chemotherapy is based on proven efficacy. This reflects clinical studies that have demonstrated that MabThera can increase survival when combined with conventional chemotherapy without additional toxicity, or compromising tolerability.1

Approximately 1.5 million people around the world are affected by NHL, which is the third fastest growing form of cancer after skin melanoma and lung cancer.2

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-oriented healthcare groups in the fields of pharmaceuticals, diagnostics and vitamins. Roche's innovative products and services address needs for the prevention, diagnosis and treatment of diseases, thus enhancing well-being and quality of life.

Roche is a world leader in oncology. Its franchise includes three drugs with survival benefit: MabThera (non-Hodgkin's lymphoma), Xeloda (colorectal cancer, breast cancer), and Herceptin (breast cancer), It also includes NeoRecormon (anaemia in various cancer settings), Roferon-A (leukaemia, Kaposi's sarcoma, malignant melan
'"/>

Contact: Rina Amin
rina.amin@ketchum.com
44-20-7611-3513
Ketchum
10-Dec-2001


Page: 1 2

Related biology news :

1. Poplar DNA code cracked -- a step in combating global warming?
2. Do genes respond to global warming?
3. Fossils reveal direct link between global warming and genetic diversity in wildlife
4. Technology already exists to stabilize global warming
5. NASA scientists get global fix on food, wood & fiber use
6. New version of premier global climate model released
7. Trapping carbon in soil key for protecting global food security, dealing with climate change
8. First ever standards linking climate change, biodiversity and poverty seek global peer review
9. 51 globally threatened species get new lease on life in the Caucasus
10. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
11. Earth, sky tapped in unique global climate change study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: